ADHD: FDA issues warning about ADHD drug Strattera

From the CEC Smart Brief:

FDA issues warning about ADHD drug Strattera The U.S. Food and Drug Administration has directed Strattera manufacturer Eli Lilly & Co. to add a warning to labels that the ADHD drug could induce suicidal thoughts in children. FDA official Thomas Laughren said the drug's benefits outweigh the risks and should be used; however, patients taking it should be monitored. Forbes (free registration) (9/29)